The Airway Microbiome and Disease
|
|
- Imogen Fox
- 5 years ago
- Views:
Transcription
1 CHEST Translating Basic Research Into Clinical Practice The Airway Microbiome and Disease Benjamin J. Marsland, PhD ; Koshika Yadava, MSc ; and Laurent P. Nicod, MD Although traditionally thought to be sterile, accumulating evidence now supports the concept that our airways harbor a microbiome. Thus far, studies have focused upon characterizing the bacterial constituents of the airway microbiome in both healthy and diseased lungs, but what perhaps provides the greatest impetus for the exploration of the airway microbiome is that different bacterial phyla appear to dominate diseased as compared with healthy lungs. As yet, there is very limited evidence supporting a functional role for the airway microbiome, but continued research in this direction is likely to provide such evidence, particularly considering the progress that has been made in understanding host-microbe mutualism in the intestinal tract. In this review, we highlight the major advances that have been made discovering and describing the airway microbiome, discuss the experimental evidence that supports a functional role for the microbiome in health and disease, and propose how this emerging field is going to impact clinical practice. CHEST 2013; 144 ( 2 ): Abbreviations : CF 5 cystic fibrosis ; IBD 5 inflammatory bowel disease ; rrna 5 ribosomal RNA The human microbiome refers to all the microbial communities that inhabit various surfaces of the human body. Bacteria form an important part of the human microbiome, and, indeed, it is well established that the human intestinal tract harbors a bacterial flora whose constituents are an order of magnitude greater in number than the cells in our body. These bacteria reside in a state of mutualism with the host, and serve many functions such as metabolizing dietary material into forms usable by the host and providing maturation signals for hematopoietic and nonhematopoietic cells of the immune system. 1 Dysbiosis of the host-microbe interaction can underlie inflammatory diseases such as inflammatory bowel disease (IBD), 2 or even obesity. 3 In recent years, analysis of bacterial 16S ribosomal DNA, the gene encoding the 16S ribosomal RNA (rrna), has revealed that the intestinal tract harbors 500 to 1,000 different species of Manuscript received November 23, 2012 ; revision accepted February 21, Affiliations: From the Faculty of Biology and Medicine, University of Lausanne, Service de Pneumologie, CHUV, Lausanne, Switzerland. Correspondence to: Benjamin J. Marsland, PhD, Service de Pneumologie, BH19.206, CHUV, 1011 Lausanne, Switzerland; benjamin.marsland@chuv.ch 2013 American College of Chest Physicians. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details. DOI: /chest bacteria. 4 16S rrna is a component of the 30S subunit of the bacterial ribosome and gene sequences encoding it contain hypervariable regions, which are conserved within bacterial species. Accordingly, with the advances in sequencing technologies, the analysis of 16S ribosomal DNA has enabled the detection and identification of several bacterial species, including many that cannot be cultured using standard microbiologic protocols. Thus, one reason underlying the expectation that the airways were sterile was that the bacteria present there could not be cultured. It is now clear, based upon work from a number of research groups worldwide, that there are bacteria resident in the airways and, additionally, the bacterial load and proportions of phyla vary under healthy or diseased conditions. In a landmark article by Hilty and colleagues 5 the airway microbiome was shown to be different between healthy individuals and those with asthma or COPD. Indeed, the Proteobacteria phylum was overrepresented in the lungs of patients with allergies and those with COPD, while the phylum Bacte roidetes was marginalized. It is interesting to note that similar changes were evident in both asthmatic and COPD airways, which raises the question of whether the change in microbiome constituents drives disease or whether inflammation per se creates a niche for the outgrowth of certain bacteria. In a recent article by Mallia et al, 6 the authors showed that 60% of individuals with 632 Translating Basic Research into Clinical Practice
2 moderate COPD developed bacterial infections following rhinovirus infection. Although no culturable bacteria were detected in these individuals prior to the rhinovirus infection, it remains possible that levels of bacteria were below the limits of detection using standard culturing protocols. It is plausible that inflammation allows the outgrowth of pathogenic bacteria, perhaps by creating a nutrient-rich niche suitable for their growth. Future studies that use molecular techniques to dissect whether these secondary infections are de novo or, in fact, represent outgrowth of the endogenous airway microbiota will provide a significant step forward in our understanding of the dynamics and implications of the airway microbiome. The Airway Microbiome in Health and Disease The origin of the airway microbiome is yet to be delineated. Endogenous flora from the intestines and the oropharynx, and/or environmental microbes could provide the initial seeding source, or, most likely, a continued source of bacteria ( Fig 1 ). A study by Charlson et al 7 suggested that the bacterial species detected in the lower respiratory tract of healthy individuals likely originated from microaspiration and reflected the micro biome detected in the upper respiratory tract. Certainly, it is critical that techniques are used to avoid possible contamination of lower respiratory tract samples by upper respiratory tract carryover; further work is required to definitively test whether contaminations from upper respiratory tract samples confound all conclusions made on the lower respiratory tract. It is nota ble that a recent study by Marri et al 8 assessed the microbiota in induced sputum of patients with mild asthma and of healthy individuals. The authors showed a clear increase in Proteobacteria in the former group as compared with healthy individuals, in line with prior studies focusing on the lower respiratory tract of patients with more severe asthma. 5 Given the ease of sample collection, these results could have implications for monitoring asthma pathogenesis and management, and suggest that the microbiome of the whole respiratory tract might be consistent; however, additional studies directly comparing different anatomic compartments of the lung are required before further conclusions can be made. In any case, the observation that the constituents of the airway microbiome change depending upon the health status of an individual (eg, having asthma or COPD) suggests there is a degree of microbe-host cross talk in the airways, and particularly encourages further analysis of its functional consequences. Figure 1. The lung microbiome in health and disease. A, Although the origins of the lung microbiome are unknown, direct exposure to environmental microbes as well as endogenous flora from the intestines and oropharynx could serve as the initial or continued inoculums. B, During homeostasis, the lung microbiome shows diversity in its composition. C, In contrast, in the diseased state, this diversity is reduced, particularly due to the outgrowth of the Proteobacteria phylum. Moreover, increases in the proportion of certain species within the different phyla have been reported. For example, an increase in the proportion of Streptococcus within the phylum Firmicutes is observed in both asthma and COPD. journal.publications.chestnet.org CHEST / 144 / 2 / AUGUST
3 Established microbial communities in the intestine exist in a dynamic state and vary in response to changes in nutrition and habitat. Future work in the respiratory field is needed to dissect whether the airway microbiome is similarly dynamic and influenced by local changes in energy sources and habitat. Nevertheless, one clear parallel between the intestine and the lung microbiomes is that a greater bacterial diversity is associated with a healthy homeostasis ( Fig 1 ). 5,9,10 An important contribution to the field came from Erb-Downward and colleagues, 10 who assessed the lung microbiome in a small cohort of never-smokers, healthy smokers, and smokers with COPD. First, the authors found a similar number of bacterial 16S rrna copies in BAL samples among all their subjects, arguing that rather than changes in the magnitude of the bacterial load, bacterial diversity might be a key differentiating factor. Indeed, in the two patients with the most severe COPD, there was evidence of reduced bacterial diversity as compared with the healthy or milder cases of COPD. This work clearly needs to be validated, but it does align with what might be expected, considering that lack of bacterial diversity in the intestinal tract is associated with an increased incidence of IBD. 11, 12 The key finding from Erb-Downward and colleagues 10 was that the microbiota is different in distinct regions of the airways. Due to the small sample size, it is premature to draw strong conclusions; however, bearing in mind that diseases such as COPD can have localized foci of inflammation or tissue damage, one can speculate that a certain microbiota might associate with that site. Cause or effect still needs to be delineated. More recently, Sze and colleagues 13 adopted a similar approach and assessed the microbiome in lung tissue of nonsmokers, healthy smokers, patients with severe COPD, and patients with cystic fibro sis (CF). Similar to Erb-Downward s group, these authors showed that the bacterial load in the lung was comparable between healthy tissue and COPD lungs, but was significantly higher in CF lungs. Again, aligning with prior work, the authors showed that the constituents of the microbiota in healthy lungs and lungs with severe COPD were distinct. A recent study compared the microbiome detectible in sputum samples from healthy individuals and patients with CF. 9 A strikingly enhanced ratio of Firmicutes to Bacteroidetes was evident in the sputum of patients with CF as compared with healthy control subjects, and b -diversity cluster analysis of both phylum- and familylevel sequence classifications revealed a clear dissimilarity between the sequences found in patients with CF and healthy individuals. Importantly, the authors added further weight to their study by associating their findings with clinical parameters. Indeed, high diversity of the bacterial flora was positively associated with reduced clinical parameters. Although thus far there is limited evidence within the context of lung transplantation, the characteristics of the airway microbiome are likely to have major effects upon lung graft functionality. Possible underlying genetic predisposition or environmental exposures coupled with immunosuppression could lead to the outgrowth or colonization of transplanted lungs with a pathogenic microbiome. One could speculate that such a microbiome could underlie the development of rejection, bronchiolitis obliterans syndrome, or certain infections. A first step toward characterizing the airway microbiome of transplant recipients was made by Charlson and colleagues. 14 In their study, they reported that the lower respiratory tract of subjects who had undergone lung transplantation had markedly higher loads of bacteria and, notably, certain fungal species were also detectible. The diversity of the microbiota was also lower in the transplant recipients, which, as mentioned earlier, has been described in COPD and is a characteristic of the intes tinal flora in IBD. A Functional Role for the Airway Microbiome? In spite of a growing bulk of literature describing the airway microbiome in different disease settings, the evidence for its function is still limited. Studies using axenic (germ-free) mice have the potential to address these questions, since these mice are completely sterile. Thus, in theory, future studies could selectively reconstitute the intestinal or airway microbiome and dissect their relative roles. Some of the first studies to address the importance of the microbiota in allergic airway disease were performed by Noverr et al. 15, 16 Their model used antibiotic therapy for the disruption of the intestinal microbiota. Although this did not eliminate the entire host microbiota, it was sufficient to cause the development of allergic airway response independent of the antigen used or the genetic background of the host mice. Consistent with their findings, in a more stringently defined model using germ-free mice, it has been shown that the complete absence of a microbiome results in pulmonary immune responses that are biased toward allergic T helper cells type 2-driven inflammation. 17 In the absence of a microbiome, the pulmonary environment contained dendritic cells and macrophages with dysregulated activation states; moreover, the germ-free mice harbored fewer alveolar macrophages, indicative of a role for the microbiome in both maturing and possibly recruiting or differentiating certain cell types (Fig 2 ). The dysregulated lung environment in the absence of a microbiome is not limited to effects upon allergic responses, with antiviral immunity against influenza virus being similarly impaired. 18 Indeed, the influenza 634 Translating Basic Research into Clinical Practice
4 Figure 2. The role of microbes in regulating allergic airway responses. A,B, Germ-free mice (lacking exposure to any bacteria, fungi, or viruses) (A) exhibit an exaggerated allergic airway response characterized by an increase in Th-2 type cytokines, airway eosinophilia, IgE, pulmonary inflammation, and airway hyperreactivity as compared with (B) mice harboring normal microflora. C, Conversely, supplementing the airway microbiome by direct airway administration of innocuous bacteria can reprogram local immune cells, eliciting a protective effect against the allergic airway response. DC 5 dendritic cell; Th2 5 T helper cells type 2. infection of germ-free mice or mice that received extensive antibiotic treatment leads to an impaired clearance of the virus and a reduced expansion of influenza-specific, cytotoxic T cells. Olszak and colleagues 19 recently showed that there is a developmental window in neonatal mice when exposure to microbes is critical for appropriate immune maturation. Using germ-free mice, the authors showed that in the absence of microbial exposure, immunecell development was dysregulated, such that there was an accumulation of invariant natural killer T cells in the lung. The consequence of this cellular accumulation was exaggerated allergic airway inflammation following allergen inhalation. One particularly important finding from this study was that germ-free mice could only be protected against the exaggerated inflammation when they were recolonized with a microbiome during the neonatal period, not when recolonized as adults. Taken together, these studies provide experimental data supporting a functionally positive effect of microbial exposure, particularly during the neonatal period. journal.publications.chestnet.org Forsythe et al 20 and Karimi et al 21 have shown that in adult mice harboring a normal microflora, oral administration of a specific bacterial strain, Lactobacillus reuteri, also attenuated airway hyperresponsiveness. Specifically, the bacterial treatment resulted in a systemic increase in regulatory T cells, which can ameliorate the allergic airway response. 21 Another study showed that inhalation of an innocuous strain of Escherichia coli could reprogram dendritic cells and macrophages in the lungs of normal mice, resulting in long-term protection against allergic responses. 22 This exposure specifically impaired aller gic responses, while leaving classic, innate responses against bacterial products such as lipopolysaccharide untouched. In this case, direct exposure to bacteria in the airways appeared to be sufficient for eliciting a protective effect ( Fig 2 ). However, one could equally speculate that colonization of mice with a microbiome from a diseased lung might have the opposite effect upon immune-cell maturation and inflammation. Indeed, a recent in vitro study 23 has shown that certain bacteria associated with patients with asthma CHEST / 144 / 2 / AUGUST
5 or COPD (pathogenic Haemophilus species and Moraxella species) intrinsically led to enhanced release of IL-23, IL12p70, and IL-10 by human monocytederived dendritic cells, as compared with bacteria associated with healthy lungs (commensal Prevotella species). Thus, within a niche in the lung, discrete interactions between certain bacterial species and the resident immune cells could potentially elicit or maintain local inflammation underlying the progression of chronic lung diseases. What Can We Learn From Other Tissues? There is a wealth of information available describing host-microbe interactions in the intestine. As mentioned earlier, species diversity is clearly linked to health, while limited diversity is associated with IBD. 11, 12 Moreover, certain bacterial species have been linked with the differentiation of inflammatory or regulatory T cells in the intestine. 24 Thus, placing the respiratory literature into the context of what is known for the intestine, there already are many parallels. This does raise the point that perhaps the phenomenon of the airway microbiome is simply a flow-on effect of what is occurring in the intestine. However, given that there are clear changes in the respiratory microbiome in diseases largely localized to the airways, such as asthma, the argument for solely an intestinal basis for the changes in the lung microbiome is fairly weak. Furthermore, in a recent study by Naik et al, 25 the authors elegantly showed that the intestinal and skin microbiomes were distinct, both in their constituents and in their functionality; specifically, direct exposure of the skin to endogenous skin bacteria was crucial for maturation of cells and appropriate immune responses against a skin infection. Such a phenomenon remains to be tested within the context of the lung, and such studies will no doubt be key to our understanding of the importance and implications of the lung microbiome. Implications for Clinical Practice As the outgrowth of certain bacteria is associated with disease severity in CF and COPD, 5,9,10,13 this could be used as an indicator for timely clinical intervention and successful disease management. Moreover, the presence of specific bacterial markers such as nucleic acids, proteins, or metabolites could be more sensitive than routine diagnostics and may also precede clinical manifestation of disease. But the ultimate goal would encompass harnessing the understanding of the microbial ecology of the airways to maintain a healthpromoting microbiome and resist colonization by pathogenic bacteria. To this end, it is crucial to define what constitutes a healthy microbiome in the airways. Studies in preclinical models will help in understanding whether dysbiosis is a cause or consequence of lung disease. Current strategies for the treatment of CF and certain exacerbations of COPD and asthma involve the use of antibiotics; given the work coming to light on possible beneficial effects of the lung microbiome, it might be a future consideration as to whether a healthy microbiome could be nurtured by selective clearance of pathogenic species by antibiotics. Another approach could be the administration of beneficial bacteria (probiotics) to compete with the pathogenic bacteria and directly or indirectly restore diversity of the airway microbial communities ( Fig 2 ). Indeed, preclinical studies involving probiotics in allergic airway inflammation have been promising. 20,26 However, clinical studies using probiotics have not shown significant protection against the incidence of asthma. 27, 28 It is important to bear in mind that these interventions involved oral administration of the probiotics. If interactions between bacterial communities and immune cells occur distinctly within the lungs, inhaled probiotics could prove to be a more effective approach. The exact formulation of such inhaled probiotics will become clearer as our understanding of the airway microbiome evolves. Interestingly, Madan et al 29 have linked the development of the respiratory microbiome in infants with CF to diet and intestinal microflora. Their study suggests that dietary manipulations alone could suffice to restore microbial diversity in the airways Conclusion On the basis of multiple studies from different international laboratories, the existence of the airway microbiome is now firmly established. Clearly, the field is still in its infancy, and key questions remain to be answered most notably, what is its function and how can we use it to prevent or treat chronic lung diseases? Is a pathogenic microbiome the basis for exacerbations of asthma and COPD? Does it provide the seed for secondary infections? Is there a link between the intestinal microbiota and the lung? As the airway microbiome gains wider acceptance, and as experimental systems develop to allow these questions to be addressed, this could be a field that helps unravel the basis of chronic lung diseases. Acknowledgments Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. References 1. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science ;336(6086): Translating Basic Research into Clinical Practice
6 2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflam matory bowel disease. Nature ;448 (7152 ): Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest ;121 (6 ): Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature ; 486 (7402 ): Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS ONE ;5 (1 ):e Mallia P, Footitt J, Sotero R, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med ;186 (11 ) Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med ; 184 ( 8 ): Marri PR, Stern DA, Wright AL, et al. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol ;131 (2 ): Blainey PC, Milla CE, Cornfield DN, et al. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med ;4 (153 ): 153ra Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the healthy smoker and in COPD. PLoS ONE ;6 (2 ):e Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A ;104 (34 ): Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut ; 53 (5 ): Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med ;185 (10 ): Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med ; 186 (6 ): Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun ;73 (1 ): Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun ;72 (9 ): Herbst T, Sichelstiel A, Schär C, et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med ;184 (2 ): Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity ;37 (1 ): Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science ;336 (6080 ): Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med ;175 (6 ): Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med ;179 (3 ): Nembrini C, Sichelstiel A, Kisielow J, Kurrer M, Kopf M, Marsland BJ. Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism. Thorax ;66 (9 ): Larsen JM, Steen-Jensen DB, Laursen JM, et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS ONE ;7 (2 ):e Round JL, Mazmanian SK. Inducible Foxp31 regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A ;107 (27 ): Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals. Science ;337 (6098 ): Feleszko W, Jaworska J, Rha RD, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy ; 37 (4 ): Forsythe P. Probiotics and lung diseases. Chest ;139 (4 ): Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol ;101 (6 ): Madan JC, Koestler DC, Stanton BA, et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio ;3 (4 ):e journal.publications.chestnet.org CHEST / 144 / 2 / AUGUST
Microbiome and Asthma
제 12 차천식연구회 COPD 연구회공동심포지엄 Microbiome and Asthma 한양대학교병원호흡기알레르기내과 김상헌 Disclosure 내용 1 Lung Microbiome 2 Lung Microbiome and Asthma 3 Gut Microbiome and Asthma Microbiome and Microbiota human microbiome
More informationGut Lung Axis Implication of the Gut Microbiota beyond its niche
Gut Lung Axis Implication of the Gut Microbiota beyond its niche Reema Subramanian PhD Candidate (4 th year) Supervisor: Prof. Margaret Ip Department of Microbiology, CUHK Joint Graduate Student Seminar
More informationThe enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago
The enteric microbiota: Implications for IBD Eugene B. Chang, M.D. University of Chicago On a per cell basis, humans are mostly prokaryote 100 90 80 70 60 50 40 30 20 10 0 EuK ProK The microbial flora
More informationThe Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain
The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain Michael T. Bailey, Ph.D. Center for Microbial Pathogenesis The Research Institute, Nationwide Children s Hospital Department
More informationDysbiosis & Inflammation
MASTERING THE MICROBIOME: Dysbiosis & Inflammation 2017 Tom Fabian, PhD It is reasonable to propose that the composition of the microbiome and its activities are involved in most, if not all, of the biological
More informationSarkis K Mazmanian, California Institute of Technology
Sarkis K Mazmanian, California Institute of Technology The human microbiota The human gut harbors 10 11-10 12 bacteria per gram colonic content (>10 14 total bacteria) Total bacteria outnumber human cells
More informationJournal of the COPD Foundation. The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?
466 COPD9USA Summary: Human Lung Microbiome Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation COPD9USA Session Summary The Human Microbiome in the Lung: Are Infections Contributing
More informationUnderstanding probiotics and health
Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,
More informationIdentifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major
More informationFecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report
Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report Qiurong Li Institute of General Surgery, Jinling Hospital Nanjing Univeristy Gut Microbiota 100 trillion cells 10-fold of
More information1/30/2016 RESPIRATORY INFECTIONS AND ASTHMA NO DISCLOSURES NO FINANCIAL INTEREST INFORMATION OBTAINED JACI AJRCCM
RESPIRATORY INFECTIONS AND ASTHMA NO DISCLOSURES NO FINANCIAL INTEREST INFORMATION OBTAINED JACI AJRCCM 1 2 year old male HISTORY -Daycare since 9 months of age -Recurrent symptoms since 10 months of age:
More informationGut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI
Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human
More informationProbiotics and Allergic Rhinitis G.A.Richards
Probiotics and Allergic Rhinitis G.A.Richards MBBCh PhD FCP(SA) FRCP Academic Head Critical Care University of the Witwatersrand Director Critical care CMJAH The Microbiome Microbial species & their associated
More informationImmunological Tolerance
Immunological Tolerance Definition: Making sure antibodies or T cells recognizing self components are either eliminated or brought under tight control. Failure of tolerance can lead to autoimmunity. (Also
More informationGut Microbiome Essentials
CORE COMPONENTS I: Gut Microbiome Essentials 2016 Tom Fabian, PhD Module Outline 1. Microbiome overview: getting a sense of the microbiome, research, what we know 2. Bacteria: features, functions, communities
More informationGut Reaction. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Gut Reaction Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Ley, R. et al (2005) PNAS vol. 102 no. 31 Bacterial diversity in the distal gut (ceca) of C57BL6 mice. (A) Phylogenetic tree of
More informationHygiene Hypothesis: 10 years later. Christina Ciaccio MD, MSc Assistant Professor The University of Chicago
Hygiene Hypothesis: 10 years later Christina Ciaccio MD, MSc Assistant Professor The University of Chicago none Disclosures Definitions Microbe: Microscopic organism Microbiota: Microbial community Definition
More informationPro/Con: Pets Prevent Allergies and Asthma
Slide 1 Pro/Con: Pets Prevent Allergies and Asthma Slide 2 Special thanks to: n Dr. Dennis Ownby n Dr. Matt Perzanowski n Dr. Erica von Mutius and Dr. Charlotte Braun-Fahrlander n Dr. Andy Liu n Colleagues
More informationThe Link Between Viruses and Asthma
The Link Between Viruses and Asthma CATHERINE KIER, MD Professor of Clinical Pediatrics Division Chief, Pediatric Pulmonary, and Cystic Fibrosis Center Director, Pediatric Sleep Disorders Center SUNY Stony
More informationThe human microbiome. Shantelle Claassen-Weitz Division of Medical Microbiology Department of Pathology.
The human microbiome Shantelle Claassen-Weitz Division of Medical Microbiology Department of Pathology tellafiela@gmail.com Source: Hamzelou, J. (2012) New Sientist, 14 April 2012, 6-7 Initial acquisition
More informationThe Human Microbiome in Chronic Obstructive Pulmonary Disease (COPD)
The Human Microbiome in Chronic Obstructive Pulmonary Disease (COPD) Jeffrey L. Curtis, M.D. University of Michigan & Ann Arbor VA Healthsystem Ning Shen, M.D. Peking University Third Hospital Outline
More informationWritten by Kate Raines Thursday, 01 December :00 - Last Updated Thursday, 14 September :41
The human microbiome plays a vital role in overall health, and new information about it is discovered nearly every day. Defined as the sum of all microbial life living in or on the human body, the microbiome
More informationPathophysiologic Basis of Autoimmune Disorders
Pathophysiologic Basis of Autoimmune Disorders Linda Felver, Ph.D., R.N. Associate Professor School of Nursing Oregon Health & Science University The immune system has two arms: Adaptive (Acquired) Immune
More informationALLERGY AND AUTOIMMUNITY
ALLERGY AND AUTOIMMUNITY Allergies and Autoimmunity Allergies and autoimmunity can be prevented It all starts in the gut It is more than preventing leaky gut IgE allergies do not necessarily involve leaky
More informationThe effect of probiotics on animal health: a focus on host s natural intestinal defenses
The effect of probiotics on animal health: a focus on host s natural intestinal defenses Guillaume Tabouret Animal Health Dept. Joint Unit 1225 Host Pathogens Interactions History of probiotics and definition
More information12/1/2017. Disclosures. Objectives. The Microbiome Defined
Can Critical Illness and the Microbiome Play Nice Together? SCOTT BOLESTA, PHARMD, BCPS, FCCM ASSOCIATE PROFESSOR OF PHARMACY PRACTICE, WILKES UNIVERSITY VISITING INVESTIGATOR, GEISINGER HEALTH SYSTEM
More informationMicrobiome in You: Optimizing Gut Bacteria for Better IBD Management
Microbiome in You: Optimizing Gut Bacteria for Better IBD Management KT Park, M.D., M.S. Assistant Professor Co-Director, Stanford Children s Inflammatory Bowel Disease Center Stanford University School
More informationBibliografia Microbiota
Bibliografia Microbiota Systematic Review: Gut Microbiota in Fecal Samples and Detection of Colorectal Neoplasms. The role of the intestinal microbiome in ocular inflammatory disease. The gut microbiome
More informationSlide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota
Slide 1 Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota Professor Barry Campbell Gastroenterology Research Unit Cellular & Molecular Physiology, Institute of Translational Medicine bjcampbl@liv.ac.uk
More informationFaecalibacterium prausnitzii
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:
More informationThe Potential For Microbiome Modification In Critical Illness. Deborah Cook
The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to
More informationThe impact of the microbiome on brain and cognitive development
The Gut-Brain Axis The impact of the microbiome on brain and cognitive development Diane Stadler, PhD, RD Oregon Health & Sciences University, Portland, Oregon Lao-American Nutrition Institute With acknowledgements
More informationTHE ROLE OF MICROBIOME IN IBD
Disclosures THE ROLE OF MICROBIOME IN IBD Janssen UCB No relevance to the talk Subra Kugathasan, MD Professor of Pediatrics & Human Genetics Marcus Professor of Pediatric Gastroenterology Emory University
More informationAsthma and the Airway Microbiome: New Insights and Hypotheses
Asthma and the Airway Microbiome: New Insights and Hypotheses Yvonne J. Huang, MD Division of Pulmonary and Critical Care Medicine Department of Internal Medicine University of Michigan, Ann Arbor 3 rd
More informationIntestinal Microbiota in Health and Disease
Intestinal Microbiota in Health and Disease February 27, 2015 Master s Course in Gastroenterology Prof. Kathy McCoy 1 Overview Overview of Gut Microbiota Microbiota in Health Microbiota in Disease 2 Gut
More informationPROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)
PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT Karen Jensen, (Retired ND) Today many people are aware of the benefits of maintaining a healthy gut. As a result, probiotic use is becoming ever more popular.
More informationNecrotizing Enterocolitis: The Role of the Immune System
Necrotizing Enterocolitis: The Role of the Immune System Patricia Denning, M.D. Associate Professor in Pediatrics Division of Neonatology Emory University School of Medicine What is NEC? What is NEC? Necrotizing
More informationAPSR RESPIRATORY UPDATES
APSR RESPIRATORY UPDATES Volume 5, Issue 7 Newsletter Date: July 2013 APSR EDUCATION PUBLICATION Inside this issue: Induced sputum A large subgroup of mild-to-moderate asthma is persistently noneosinophilic
More informationMicrobiome GI Disorders
Microbiome GI Disorders Prof. Ram Dickman Neurogastroenterology Unit Rabin Medical Center Israel 1 Key Points Our gut microbiota Were to find them? Symbiosis or Why do we need them? Dysbiosis or when things
More informationAppendix E1. Epidemiology
Appendix E1 Epidemiology Viruses are the most frequent cause of human infectious diseases and are responsible for a spectrum of illnesses ranging from trivial colds to fatal immunoimpairment caused by
More informationAntibiotic Resistance and Probiotics - A Metagenomic Viewpoint
Antibiotic Resistance and Probiotics - A Metagenomic Viewpoint Neerja Hajela, PhD General Manager-Science & Regulatory Affairs Yakult Danone India Pvt. Ltd. Outline of the Presentation Global Epidemiology
More information2/13/2018. What s bugging you? Relevance of the Human Microbiome in Health and Disease Heidi H. Kong, MD, MHSc, FAAD Dermatology Branch
What s bugging you? Relevance of the Human Microbiome in Health and Disease Heidi H. Kong, MD, MHSc, FAAD Dermatology Branch DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Heidi H Kong, MD, MHSc, FAAD U017:
More informationNasal and Sinus Microbiome: the potential for microbiota-targeted therapeutics
Nasal and Sinus Microbiome: the potential for microbiota-targeted therapeutics Katherine P. Lemon, M.D., Ph.D. Microbiome Transplantation Working Group December 3, 2015 & Boston Children s Hospital Microbes
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline Consensus characteristics/incidence data Immune/inflammatory basis Etiology/Genetic basis Hygiene
More informationSearching for Targets to Control Asthma
Searching for Targets to Control Asthma Timothy Craig Distinguished Educator Professor Medicine and Pediatrics Penn State University Hershey, PA, USA Inflammation and Remodeling in Asthma The most important
More informationTRANSATLANTIC AIRWAY CONFERENCE
The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations Yvonne J. Huang and Homer A. Boushey Division of Pulmonary and Critical Care Medicine, University of Michigan Health System,
More informationThe role of gut microbiome in IBS
The role of gut microbiome in IBS Chung Owyang, MD H. Marvin Pollard Professor of Internal Medicine Professor of Molecular and Integrative Physiology Chief, Division of Gastroenterology Director, Pollard
More informationToday s talk 21/05/2017. Microbiota: the consequence of evolution! Probiotics and mucosal immunity interactions in early life.
Europe Probiotics and mucosal immunity interactions in early life Almere, 09 Mei, 2017 Today s talk The dynamics of the microbiota The required signals from the environment Not all signals (probiotics!)
More informationAccepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo
Accepted Manuscript Innate immune cells regulate oncoimmunity and cancer development Ai-Ping Bai, Yuan Guo PII: S0016-5085(18)34974-6 DOI: 10.1053/j.gastro.2018.08.057 Reference: YGAST 62119 To appear
More informationMicrobiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy
Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy Giuliana Magri, Ph.D Optimizing Immunotherapy New Approaches, Biomarkers, Sequences and Combinations PRBB Auditorium, Barcelona October
More informationExosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE
Exosomes as a Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE Endocrine Nurse Practitioner Institute for Hormonal Balance Orlando, FL Medical Director Ward-Murray
More informationInnate immune regulation of T-helper (Th) cell homeostasis in the intestine
Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,
More informationINTRODUCING YOUR GUT BACTERIA
INTRODUCING YOUR GUT BACTERIA Microflora Intestinal flora 1.5 kg We would die with 5 years of birth if we did not have them as we would not develop a proper immune system 1000 species and 5000 strains
More informationHUMAN GUT MICROBIOTA
HUMAN GUT MICROBIOTA Patrizia Brigidi Department of Pharmaceutical Sciences, University of Bologna, Italy patrizia.brigididi@unibo.it The Gut-Liver axis: a bidirectional relation in health and disease
More informationPROBIONA. PROBIOTICS with 5 bacterial strains. Suitable during and after the use of antibiotics to restore intestinal microflora.
PROBIONA Probiotic supplement for adults PROBIOTICS with 5 bacterial strains Suitable during and after the use of antibiotics to restore intestinal microflora. 2.850 billion cfu per capsule guaranteed
More information17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012
17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 The Sagamore Resort, Bolton Landing, NY, USA The following report includes highlights
More informationHOW THE MICROBIOME AFFECTS OUR HEALTH
HOW THE MICROBIOME AFFECTS OUR HEALTH THE INTESTINAL BARRIER AND INTESTINAL PERMEABILITY Intestinal Barrier: a functional body Defense from translocation of dietary antigens, bacteria or bacterial endotoxins
More informationGoing With Your Gut: The Microbiome and You
Going With Your Gut: The Microbiome and You Robert T. Schooley, MD Professor of Medicine University of California San Diego San Diego, California Learning Objectives After attending this presentation,
More informationThe Intestinal Microbiota and the Developing Immune System
The Intestinal Microbiota and the Developing Immune System 4 Feb 2016 The Intestinal Microbiota 10 fold more bacterial cells than human cells 100-1000 fold more bacterial genes than human genes Why does
More informationRole of the Gut Microbiota in Autoimmunity
Role of the Gut Microbiota in Autoimmunity Pavan Bhargava, MD - Neuroimmunology Fellow Division of Neuroimmunology and Neurological Infections Johns Hopkins University, Baltimore, MD. May, 2015 None Disclosures
More informationThe microbiome and respiratory inflammation
EARN 3 FREE CPD POINTS Respiratory Leader in digital CPD for Southern African healthcare professionals The microbiome and respiratory inflammation Professor Robin Green Paediatric Pulmonologist Faculty
More informationAn Update in COPD John Hurst PhD FRCP
An Update in COPD John Hurst PhD FRCP Reader in Respiratory Medicine / Honorary Consultant University College London / Royal Free London NHS Foundation Trust j.hurst@ucl.ac.uk What s new in COPD papers
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationGUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?
GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH? Corrie Whisner, PhD School of Nutrition and Health Promotion Arizona State University Center for Research on Ingredient Safety Annual Meeting
More informationLavanya Nutankalva,MD Consultant: Infectious Diseases
Lavanya Nutankalva,MD Consultant: Infectious Diseases Introduction The word Probiotic was derived from the Greek phrase meaning for life." was first coined in the 1960s by Lilly and Stillwell. Probiotics
More informationThe number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.
The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells. The number of microorganisms residing in our intestines is 10 times the number of our somatic
More informationMicrobiome. A new dimension in Medicine. Israel De Alba, MD MPH. Clinical Professor
Microbiome A new dimension in Medicine Israel De Alba, MD MPH Clinical Professor AIM To look at ordinary things from a different perspective.to jump start curiosity Reason to have lunch We know so much
More informationCurrent Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook
Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics Deborah Cook Objectives VAP The Old: Gastropulmonary route of infection The New: Microbiome modification Role of acid suppression Influence
More informationDiet and the Human Gut Microbiome: Whose diet is it anyway?
Soy Nutrition Institute Meeting Minneapolis, MN August 23-24, 2018 Diet and the Human Gut Microbiome: Whose diet is it anyway? Johanna W. Lampe, PhD, RD Public Health Sciences Division Fred Hutchinson
More informationFunctional Nutrition Approaches to Gut Health 20 CPEU Module accredited by Nutrition Mission
Topics Covered 1. Good Health Starts in the Gut 2. Microbiome Part 1 3. Microbiome Part 2 4. What Can Go Wrong 5. FODMAP Intolerance 6. GERD 7. Celiac Disease 8. Non-Celiac Gluten Sensitivity 9. Intestinal
More informationUpdate on Immunology 12/31/12. Disclosures. Outline. Outline. Outline. Pathophysiology of Allergic Disease. Allergy background Novel T cell subsets
Update on Immunology Mitchell H. Grayson, MD Associate Professor Medical College of Wisconsin Dec 2012 Disclosures Employer Medical College of Wisconsin Research support National Institutes of Health $100,000
More informationThe A, B, C s of Bowel Flora
The A, B, C s of Bowel Flora Cynthia L. Sears, M.D. Divisions of Infectious Diseases, Gastroenterology & Tumor Immunology Departments of Medicine, Oncology & Molecular Microbiology Sidney Kimmel Comprehensive
More informationIt Takes Guts to Grow a Brain. Josef Neu, M.D. University of Florida
It Takes Guts to Grow a Brain Josef Neu, M.D. University of Florida neuj@peds.ufl.edu The Versatile Intestine: The intestine is not only a digestive-absorptive organ Largest immune organ of the body. Harbors
More informationINTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES
EXAMPLES OF INDIVIDUAL ANALYSES INTESTINAL MICROBIOTA Microbiota in the animal or human intestine has evolved together with the host. Consequently, the gastrointestinal tract could be considered a metacommunity,
More informationمحاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases
محاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases Immunity to infection depends on a combination of innate mechanisms (phagocytosis, complement, etc.) and antigen
More informationEat Dirt: Why Cleanliness is Bad for Asthma
Eat Dirt: Why Cleanliness is Bad for Asthma Joel N. Kline MD MSc Professor, Pulmonary Medicine Director: UI Adult Asthma Center Director, Clinical Research ICTS University of Iowa Iowa City, IA 1 Disclosures:
More informationSkin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease
Skin reactivity to autologous bacteria 149 Original Article Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease J. Halasa 1, M. Halasa
More informationBreastfeeding and the Microbiome
Breastfeeding and the Microbiome JENNY WALTERS MPH, IBCLC Objectives At the conclusion of this session, participants will be able to: Identify ways the microbiota is passed from mother to baby Identify
More informationMegaSporeBiotics Probiotics. Linda Wilbert - Stewart, FDN, HHP, HC 1/28/
MegaSporeBiotics Probiotics www.exclusivelyholistic.com Linda Wilbert - Stewart, FDN, HHP, HC 1/28/2015 111 MegaSporeBiotic is the first, all spore, carotenoid rich, probiotic consortium formulation on
More informationMucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz
Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology Robin Lorenz rlorenz@uab.edu Why do we Need to Understand How the Mucosal Immune System Works? The mucosa is the major
More informationTolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF
Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells
More informationGut microbiota, metabolic syndrome, obesity and the nutrient sensor pathways
Gut microbiota, metabolic syndrome, obesity and the nutrient sensor pathways Department of Gastroenterology, Endocrinology & Metabolism Medical University Innsbruck Herbert Tilg Nothing to disclose Fig.
More informationGenetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD
Advances in the Pathogenesis of IBD: Genetics Leads to Function Pathogenesis of IBD Environmental Factors Microbes Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationReduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats
Microbiol. Immunol. Vol. 21 (9), 495-503, 1977 Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats Tsugio WATANABE, Masami MOROTOMI,
More informationAsthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK
Dr Neil Williams Nottingham Trent University College of Science and Technology Department of Sport Science Email: neil.williams@ntu.ac.uk @NeilW_ExPhys 1 Asthma In Europe ~30 million children and adults
More informationHow Gut Microbes Alter the Risks of RSV Infection and Asthma in Mice and Men
How Gut Microbes Alter the Risks of RSV Infection and Asthma in Mice and Men Dennis R. Ownby MD Medical College of Georgia at Augusta University Disclosures No commercial financial relationships No discussion
More informationExploration of the microbiota in inflammatory diseases. Matthew Stoll MD Research Computing Day September 13, 2012
Exploration of the microbiota in inflammatory diseases Matthew Stoll MD Research Computing Day September 13, 2012 We re surrounded by bugs Human body contains 100 trillion microbes Out-number human cells
More informationEffector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells
ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction
More informationResearch Reveals the Importance of Your Microbiome Gut Health for Optimal Health
Research Reveals the Importance of Your Microbiome Gut Health for Optimal Health Fifteen years ago, it was anticipated the Human Genome Project (HGP) would allow modern medicine to leapfrog into groundbreaking
More informationWhat are probiotics? How do probiotics benefit health?
The culture club So, you re clean eating, gluten free, fasting, eating avocados like their going out of fashion, chugging down green juices with the latest wonder powders and using coconut oil to cook
More informationNormal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine
Normal Human Flora (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine 2014-2015 Objectives Describe important human normal flora. Demonstrate the epidemiology of human normal flora. Determine
More informationHMP is lead by NIH but is an International Consortium.
Human Microbiome The Human Microbiome Project was one of the spin offs of the Human Genome Project. The HMP project started in 2007 with the overall goal of Characterizing the Human Microbiome and determine
More informationSIMPOSIO Il microbiota intestinale e la sua modulazione nelle patologie dell asse intestino cervello. Microbiota e IBS.
SIMPOSIO Il microbiota intestinale e la sua modulazione nelle patologie dell asse intestino cervello Microbiota e IBS Cesare Cremon Policlinico S. Orsola Malpighi Azienda Ospedaliero - Universitaria di
More informationHuman intestinal microbiology and probiotics
Human intestinal microbiology and probiotics Michiel Kleerebezem Wageningen Centre for Food Sciences Wageningen University NIZO food research P.O. Box 20 6710 BA Ede The Netherlands phone: +31-(0)318-659629
More information7/30/2018. Nutricia North America 1. Learning Objectives
Probiotics, Prebiotics and the Role of the Infant Intestinal Microbiota in Health and Allergic Disease Kelly Tappenden, Ph.D, R.D. Kelly Tappenden, Ph.D, R.D. Professor and Department Head Department of
More informationTolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationThe human microbiome and how it affects heath. Nafisa M. Jadavji, PhD
The human microbiome and how it affects heath Nafisa M. Jadavji, PhD NafisaJadavji@cunet.carleton.ca Lecture Outline Housekeeping Introduction Research Initiatives to Understand Microbiome Microbiota Development
More informationThe Human Microbiome: Medical, Philosophical, and Theological Complexity
The Human Microbiome: Medical, Philosophical, and Theological Complexity John Pohl MD Professor of Pediatrics Division of Pediatric Gastroenterology University of Utah Salt Lake City, Utah Twitter: @jfpohl
More information